课题基金 / 基金详情

Development and Validation of a Clinical Prediction Rule for Pediatric Pneumonia

Development and Validation of a Clinical Prediction Rule for Pediatric Pneumonia
小儿肺炎临床预测规则的制定和验证
批准号:
9252817
负责人:
Derek J. Williams
金额:
$12.95万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-02-01 至 2018-01-31

项目摘要

项目成果

Derek J. Williams的其他基金

相关文献

中文摘要
翻译
描述(申请人提供):肺炎是全球儿童的头号杀手,每年造成五分之一的儿科死亡,包括每年近200万名5岁以下儿童的死亡。在美国,尽管总体死亡率较低,肺炎仍然是儿童住院的最常见指征,相当大比例的儿童患有严重疾病,需要加强心肺干预和延长住院时间。尽管有这种巨大的负担,但在肺炎儿童的疾病严重程度和预期结果的确切决定因素方面仍存在实质性的知识差距。其结果是管理方面的广泛差异--包括护理地点决定、诊断测试和抗菌剂的使用--对个人结果和社会成本产生下游影响。因此,提高我们对肺炎疾病严重性的了解,包括准确预测结果的能力,是尚未得到满足的需求的关键领域。这项建议中详述的研究直接回应了这一需求,并包括以下科学目标:1)开发并严格验证使用比例优势Logistic回归预测社区获得性肺炎(CAP)住院儿童严重结局风险的临床预测RUE;2)将微生物学数据的测定纳入模型中,以评估肺炎病原学对预测规则性能特征的影响;3)外部验证临床预测规则 到急诊科就诊的CAP患儿的前瞻性观察队列中的预测规则。在过去的两年半里,这位候选人与他的导师和其他调查人员密切合作,对美国三个城市的儿童CAP住院情况进行前瞻性、基于人群的监测,以确定发病率和全面的微生物病因。这项研究包括2500多名患有CAP的儿童,并将作为发展和初步确认拟议的预后研究(科学目标1和2)的唯一数据来源。目标3将招收300名儿童参加 急诊科要求在前瞻性验证研究中因CAP入院,以确保开发的模型在新人群中的准确预测性能,并评估其潜在的临床适用性。这种有指导的职业发展经验的首要目标是让应聘者成为一名独立的临床调查员,领导一个多学科研究计划,以改善肺炎儿童的护理和预后。为了实现这一目标,应聘者将通过在预测建模、临床研究、实施科学和领导力培训方面的高级课程和实践技能发展来加强他之前的研究培训。在整个获奖期间,候选人将与一个由多学科导师和顾问组成的团队密切合作--包括传染病、生物统计学、医院医学和流行病学方面的专家--以实现他宣布的职业生涯和科学目标。
英文摘要
DESCRIPTION (provided by applicant): Pneumonia is the leading killer of children worldwide, responsible for one in five pediatric deaths annually, including nearly 2 million deaths each year among children less than 5 years of age. In the United States (US), despite low overall mortality, pneumonia remains the most common indication for hospitalization among children, with a significant proportion of children experiencing severe disease requiring intensive cardiorespiratory interventions and prolonged hospitalization. Despite this enormous burden, substantial knowledge gaps exist regarding precise determinants of disease severity and expected outcomes for children with pneumonia. The result is wide variation in management-including site of care decisions, diagnostic testing, and use of antimicrobials-with downstream effects on individual outcomes and societal costs. Thus, improving our understanding of pneumonia disease severity, including the ability to accurately predict outcomes, is a critical area of unmet need. The research detailed in this proposal responds directly to this need and includes the following scientific aims: 1) Develop and rigorously validate a clinical prediction rue using proportional odds logistic regression that predicts risk for severe outcomes among children hospitalized with community-acquired pneumonia (CAP); 2) Incorporate the determination of microbiologic data into the model to assess the influence of pneumonia etiology on performance characteristics of the prediction rule; 3) Externally validate the clinical prediction rule among a prospective observational cohort of children presenting to the emergency department with CAP. For the past two and one half years, the candidate has worked closely with his mentor and other investigators to conduct prospective, population-based surveillance for CAP hospitalizations among children in three US cities to determine disease incidence and comprehensive microbiologic etiology. This study includes over 2500 children with CAP and will serve as the exclusive data source for the development and initial validation of the proposed prognostic studies (scientific aims 1 and 2). Aim 3 will enroll 300 children in the emergency department requiring hospital admission for CAP in a prospective validation study to ensure accurate predictive performance of the developed models in new populations and assess their potential clinical applicability. The overarching objective of this mentored career development experience is for the candidate to emerge as an independent clinical investigator leading a multidisciplinary research program to improve care and outcomes for children with pneumonia. To accomplish this goal, the candidate will augment his prior research training with advanced coursework and practical skills development in predictive modeling, clinical research, implementation science, and leadership training. Throughout the award period, the candidate will work closely with a multidisciplinary team of mentors and advisors-including experts in infectious diseases, biostatistics, hospital medicine, and epidemiology-to carry out his stated career and scientific aims.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1093/ofid/ofw071
发表时间: 2016-03
期刊: Open forum infectious diseases
影响因子: 4.2
作者: [Diaz MH, Cross KE, Benitez AJ, Hicks LA, Kutty P, Bramley AM, Chappell JD, Hymas W, Patel A, Qi C, Williams DJ, Arnold SR, Ampofo K, Self WH, Grijalva CG, Anderson EJ, McCullers JA, Pavia AT, Wunderink RG, Edwards KM, Jain S, Winchell JM]
通讯作者: Winchell JM
DOI: 10.1093/jpids/piw091
发表时间: 2018-02-19
期刊: Journal of the Pediatric Infectious Diseases Society
影响因子: 3.2
作者: [Stockmann C, Ampofo K, Killpack J, Williams DJ, Edwards KM, Grijalva CG, Arnold SR, McCullers JA, Anderson EJ, Wunderink RG, Self WH, Bramley A, Jain S, Pavia AT, Blaschke AJ]
通讯作者: Blaschke AJ
DOI: 10.1093/ofid/ofv106
发表时间: 2015-09
期刊: Open forum infectious diseases
影响因子: 4.2
作者: [Diaz MH, Benitez AJ, Cross KE, Hicks LA, Kutty P, Bramley AM, Chappell JD, Hymas W, Patel A, Qi C, Williams DJ, Arnold SR, Ampofo K, Self WH, Grijalva CG, Anderson EJ, McCullers JA, Pavia AT, Wunderink RG, Edwards KM, Jain S, Winchell JM]
通讯作者: Winchell JM
Reply to Chalmers et al.
回复查尔默斯等人。
DOI: 10.1093/cid/ciw466
发表时间: 2016
期刊: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子: --
作者: [Self,WesleyH, Wunderink,RichardG, Williams,DerekJ, Waterer,GrantW, Jain,Seema, Edwards,KathrynM, Grijalva,CarlosG]
通讯作者: Grijalva,CarlosG
共 14 条
    Reducing Overuse of Antibiotics with Decision Support: The ROADS Study
    Development and Validation of a Clinical Prediction Rule for Pediatric Pneumonia
    • 批准号:
      8800539
    • 项目类别:
    • 资助金额:
      $17.21万
    • 财政年份:
      2013
    • 负责人:
      Derek J. Williams
    • 依托单位:
    Development and Validation of a Clinical Prediction Rule for Pediatric Pneumonia
    • 批准号:
      8998917
    • 项目类别:
    • 资助金额:
      $4.26万
    • 财政年份:
      2013
    • 负责人:
      Derek J. Williams
    • 依托单位:
    Development and Validation of a Clinical Prediction Rule for Pediatric Pneumonia
    • 批准号:
      8487319
    • 项目类别:
    • 资助金额:
      $17.21万
    • 财政年份:
      2013
    • 负责人:
      Derek J. Williams
    • 依托单位: